Hypertensiologie 2007

Was ist neu?

• Behandlungsqualität der Hypertonie in Deutschland deutlich verbessert

• Schlaganfälle in den letzten Jahren rückläufig

• Weniger Kochsalz, mehr Schokolade senkt den Blutdruck und die Mortalität

• Neues von der J-Kurve

• Erster Renin-Inhibitor zugelassen

Literatur

• 1 Adrogué H J, Madias N E. Sodium and Potassium in the Pathogenesis of Hypertension.  N Eng J Med. 2007;  356 196-178
• 2 Appel L J, Moore T J. et al. for the DASH Collaborative Research Group . A clinical trial of the effects of dietary patterns on blood pressure.  N Engl J Med. 1997;  336 1117-1124
• 3 Buijsse B, Feskens E, Kok F, Kromhout D. Cocoa Intake, Blood Pressure, and Cardiovascular Mortality. The Zutphen Elderly Study.  Arch Intern Med. 2006;  166 411-417
• 4 Cook N R, Cutler J A, Obarzanek E. et al . Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP).  BMJ. 2007;  Apr 28; 334 (7599) 885
• 5 Gradman A H. et al . Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients.  Circulation. 2005;  111 1012-1018
• 6 Julius S t. et al . Feasibility of Treating Prehypertension with an Angiotensin-Receptor Blocker.  N Engl J Med. 2006;  354 1685-1697
• 7 Lemmer B, Middeke M, Schaaf B, Eckes L. Prescribing practices and morning blood pressure control: results of a large scale, primary-care study conducted in germany. 21st Scientific Meeting of the Int Soc Hypertens, Proceedings, abstract p.94 2006
• 8 Löwel H, Meisinger C. et al . Epidemiologie der arteriellen Hypertonie in Deutschland.  Dtsch Med Wochenschr. 2006;  131 2586-2591
• 9 MacGregor G A, Sagnella G A. et al . Double-blind study of three sodium intakes and long-term effects of sodium restriction in essential hypertension.  Lancet. 1989;  11 1244-1247
• 10 Meisinger C, Heier M, Völzke H. et al . Regional disparities of hypertension prevalence and management within Germany.  Hypertension. 2006;  24 293-299
• 11 Messerli F H, Mancia G, Conti R. et al . Dogma Disputed: Can Aggressively Lowering Blood Pressure in Hypertensive Patients with Coronary Artery Disease Be Dangerous?.  Ann Intern Med. 2006;  144 884-893
• 12 Middeke M. Die U-förmige Beziehung zwischen nächtlichem Blutdruck und Organschäden.  Dtsch Med Wochenschr. 2005;  130 2640-2642
• 13 Schroeter H, Heiss Ch. et al . (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans.  Proc Natl Acad Sci U S A. 2006;  103 1024-1029
• 14 Silber S. Ergebnisse einer Snapshot Umfrage des BNK. 30. Wiss. Kongress der Deutschen Hochdruckliga, München 2006
• 15 Statistisches Bundesamt Deutschland - .Gesundheitswesen. www.gbe-bund.de
• 16 van Tassell B, Munger M. Aliskiren for Renin Inhibition: A New Class of Antihypertensives.  The Annals of Pharmacotherapy. 2007;  41 456-464
• 17 Wang Y, Alexander G, Stafford R. Outpatient Hypertension Treatment, Treatment Intensification, and Control in Western Europe and the Unites States.  Arch Intern Med. 2007;  167 141-147
• 18 Wolf-Maier K, Cooper R. et al . Hypertension Prevalence and Blood Pressure Levels in 6 European Countries, Canada, and the United States.  JAMA. 2003;  289 2363-2369
• 19 Wood J M, Maibaum J, Rahuel J. Structure based design of alsikiren, a novel orally effective renin inhibitor.  Biochem Biophys Res Commun. 2003;  308 698-705